Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EUDA Health Holdings ( (EUDA) ) has shared an announcement.
On December 5, 2025, EUDA Health Holdings Limited announced the execution of a securities purchase agreement with Streeterville Capital, LLC, involving the sale of a convertible warrant for $100,000. This agreement is part of EUDA’s strategy to strengthen its capital position and expand its footprint in Asia’s non-invasive healthcare market, aiming to enhance its healthcare ecosystem and create long-term value for stakeholders.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based leading non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China. The company aims to lead in non-invasive and preventive healthcare, targeting the fast-growing longevity sector and addressing the healthcare needs of over 1.8 billion people in the region.
Average Trading Volume: 100,781
Technical Sentiment Signal: Hold
Current Market Cap: $107.8M
For a thorough assessment of EUDA stock, go to TipRanks’ Stock Analysis page.